Given the existing evidence linking cardiovascular risk factors, lifestyle, APOE genotype, and telomere attrition to cognitive impairment, exploring these interactions can enhance our understanding of the cellular aging mechanisms involved in AD development and validate telomere attrition as a potential biomarker for AD. This evidence concerns the gene APOE and Alzheimer disease.